
Inventurus Knowledge Solutions Limited
Inventurus Knowledge Solutions Limited(IKS)
Total Shares
1,87,95,510
Issue Size
₹2,497.92
Price Band
₹1265 – ₹1329
Lot Size
11 shares
Min. Investment
₹14,619
Max. Investment
₹14,619
Open Date
12 Dec, 2024
Close Date
16 Dec, 2024
Allotment
17 Dec, 2024
Listing
19 Dec, 2024
Max. Investment
₹14,619
Announced
12 Dec, 2024
Opening Date
12 Dec, 2024
Closing Date
16 Dec, 2024
Basis of Allotment
17 Dec, 2024
Initiation of Refunds
18 Dec, 2024
Credit of Shares
18 Dec, 2024
Listing Date
19 Dec, 2024
Live GMP
Est. Listing: ₹1604
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Inventurus Knowledge Solutions Limited IPO
Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) provides services to healthcare enterprises such as handling administrative chores/work. The company helps doctors and other healthcare providers by handling their paperwork and administrative tasks. IKS Health offers services such as clinical support, medical documentation management, virtual medical scribing and more.
The company is a healthcare technology company that helps make i
Inventurus Knowledge Solutions Limited IPO Share Price and Issue Size
Issue Breakdown
Shareholding
Dilution: 0.0% increase in shares
Inventurus Knowledge Solutions Limited IPO Financials Health
Inventurus Knowledge Solutions Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 11 | ₹14,619 |
| Retail Maximum | 13 | 143 | ₹1,90,047 |
| SHNI Minimum | 14 | 154 | ₹2,04,666 |
| SHNI Maximum | 68 | 748 | ₹9,94,092 |
| BHNI Minimum | 69 | 759 | ₹10,08,711 |
(All values in CR)
Inventurus Knowledge Solutions Limited IPO Valuation
| Metric | Value |
|---|---|
| Debt/Equity | -0.06 |
| EPS Post IPO | 21.59 |
| EPS Pre IPO | 21.59 |
| PAT Margin (%) | 20.38 |
| ROE | 32% |
| RoNW | 32% |
(All values in CR)
Strength & Risk of Inventurus Knowledge Solutions Limited IPO
1. Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.
2. Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.
3. Strong brand driven by clinical thought leadership through IKS Advisory Board, a healthcare industry leadership forum, and partnerships with industry players and evident through multiple awards and recognitions.
4. Marquee large enterprise clientele that include academic medical centres and healthcare systems, multispecialty and single-specialty medical groups, ancillary healthcare organizations, value enablers, and other outpatient healthcare delivery organizations and client stickiness reflected in revenues from repeat clients of over 98% in the last three Fiscals.
5. Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.
6. Healthy financial performance with growth and improving margins.
7. Experienced and entrepreneurial driven leadership team.
1. There have been certain FEMA related deficiencies in compliances in the past by our Company and some of our existing and erstwhile shareholders, with respect to issuance of securities of our Company, delays in relation to reporting requirements and transfer of securities of our Company. We have filed compounding applications with the RBI in respect of such contraventions, which are currently pending. Consequently, we may be subject to regulatory actions and penalties/ compounding fees, as applicable.
2. We have outstanding litigation against us, an adverse outcome of which may adversely affect our business, reputation and results of operations.
3. If we fail to successfully develop and introduce new solutions based on artificial intelligence and machine learning technologies and features to existing solutions such as AI-powered speech-to-text solutions, our revenues, operating results and reputation could suffer.
4. The healthcare industry is regulated and if we fail to comply with applicable healthcare laws and government regulations, we could incur financial penalties, be required to make significant operational changes or experience adverse publicity, which could harm our business.
5. Various challenges currently faced by the healthcare industry in the United States including the provision of quality healthcare in a competitive environment and managing costs at the same time and consolidation of healthcare organizations in the United States may adversely affect our business, results of operations and financial condition.
6. Our revenues are dependent on our ability to maintain and expand existing client relationships and our ability to attract new clients. As of September 30, 2024 and 2023 and as of March 31, 2024, 2023 and 2022, we had 778, 42, 853, 49 and 45 clients. A loss of one or more clients could have an adverse impact on our results of operations, financial condition and cash flows.
7. We have recently acquired Aquity Holdings to further our strategic objectives. Our inability to successfully integrate the operations of Aquity or the operations of any entities that we may acquire could adversely impact our business, financial condition, results of operations, cash flows and prospects.
8. Our Company will not receive any proceeds from the Offer. Some of our Shareholders are selling shares in the Offer and will receive proceeds as part of the Offer for Sale.
9. Delays in receiving payment of outstanding dues from clients may affect our financial condition and results of operations.
10. Our revenues are primarily dependent on revenue generated from healthcare organizations based in the United States, and as a result, we are subject to the risks of sector and geographic concentration.
Inventurus Knowledge Solutions Limited IPO Subscription Status
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 84,28,730 | 84,28,730 | 1 |
| BHNI (10L+) | 24.99 | 18,73,051 | 4,68,14,878 | 6 |
| Employees | 5.20 | 65,000 | 3,37,898 | 44.91 |
| HNI | 23.25 | 28,09,577 | 6,53,29,990 | 8 |
| QIB | 80.64 | 56,19,154 | 45,31,55,846 | 60 |
| Retail | 14.55 | 18,73,050 | 2,72,57,252 | 3 |
| SHNI (2L - 10L) | 19.77 | 9,36,525 | 1,85,15,112 | 2 |
| Total | 52.68 | 1,03,66,781 | 54,60,80,986 | 72 |
Inventurus Knowledge Solutions Limited IPO GMP
Last updated 09 Dec, 2024 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 09 Dec, 2024 | 1329 | ₹275▼ | 2300/32200 | ₹1,604 (20.69%) | - | 09 Dec, 2024 |
| 10 Dec, 2024 | 1329 | ₹350▼ | 2900/40600 | ₹1,679 (26.34%) | - | 10 Dec, 2024 |
| 11 Dec, 2024 | 1329 | ₹422 | 3500/49000 | ₹1,751 (31.75%) | - | 11 Dec, 2024 |
| 12 Dec, 2024 | 1329 | ₹422▲ | 3500/49000 | ₹1,751 (31.75%) | - | 12 Dec, 2024 |
| 13 Dec, 2024 | 1329 | ₹375 | 3100/43400 | ₹1,704 (28.22%) | - | 13 Dec, 2024 |
| 14 Dec, 2024 | 1329 | ₹375▼ | 3100/43400 | ₹1,704 (28.22%) | - | 14 Dec, 2024 |
| 16 Dec, 2024 | 1329 | ₹405▼ | 3400/47600 | ₹1,734 (30.47%) | - | 16 Dec, 2024 |
| 17 Dec, 2024 | 1329 | ₹421▲ | 3500/49000 | ₹1,750 (31.68%) | - | 17 Dec, 2024 |
| 18 Dec, 2024 | 1329 | ₹407▼ | 3400/47600 | ₹1,736 (30.62%) | - | 18 Dec, 2024 |
| 19 Dec, 2024 | 1329 | ₹421 | 3500/49000 | ₹1,750 (31.68%) | - | 19 Dec, 2024 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Inventurus Knowledge Solutions Limited IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Inventurus Knowledge Solutions Limited under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.